Related Experiment Video
Updated: May 10, 2025

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Published on: August 12, 2021
Ag2S/Zn2+-Decorated g-C3N4 Type-II Heterojunction with Wide-Spectrum Response: Construction and Photocatalytic
Chengyang Wang1, Han Zheng1, Ruxue Ma1
1College of Chemistry, Zhengzhou University, Zhengzhou 450001, China.
Abstract:
Antibiotic-based wastewaters seriously endanger human health and damage the ecological environment, and photocatalytic degradation is a desirable strategy for eliminating these contaminants in water. Therefore, developing a proper catalyst for the photodegradation of antibiotics, including ciprofloxacin (CIP), is of great importance. In this study, novel Ag2S/Zn2+-decorated graphitic carbon nitride (AZCN for short) type-II heterojunctions are constructed through a precipitation-calcination procedure. The high porosity with a specific surface area of 133.5 m2 g-1, as well as the positive synergy between Ag2S- and Zn2+-decorated graphitic carbon nitride (abbreviated as ZCN), enhance incident light harvesting, increase the adsorption capacity for reactant molecules, favor mass transfer and promote the separation and transport of photoinduced carriers, therefore improving the degradation efficiency of CIP. Specifically, the degradation efficiency of CIP (50 mL, 10 mg L-1) over 2.5% AZCN (10 mg) is 18.1%, 43.1% and 55.7% within 60 min of irradiation using near-infrared light, visible light and simulated solar light, respectively. Moreover, it displays satisfactory recycling stability and excellent universality. This research not only develops a promising heterojunction photocatalyst but also offers some valuable insights in water remediation.
Related Concept Videos
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Affinity and Avidity
Relative Motion Analysis - Acceleration
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
GPCRs Regulate Adenylyl Cylase Activity

